Clinical trials
Phase 1 Prostatic Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aragon Pharmaceuticals, Inc. | 2 |
| AstraZeneca | 2 |
| Janssen Research & Development, LLC | 2 |
| The Netherlands Cancer Institute | 2 |
| Amgen | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Blue Earth Therapeutics Ltd | 1 |
| Bracco Diagnostics, Inc | 1 |
| Clinical Research Office of the Endourological Society | 1 |
| Erasmus Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 18 |
| Neoplasms | 2 |
| Bites and Stings | 1 |
| Breast Neoplasms | 1 |
| Genital Diseases, Male | 1 |
| Genital Neoplasms, Male | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms by Site | 1 |
| Prostatic Diseases | 1 |
| Prostatic Neoplasms, Castration-Resistant | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.